miR-199a-5p regulates β1 integrin through Ets-1 to suppress invasion in breast cancer

Wentong Li1, Hui Wang2, Jinbao Zhang3

  • 1Department of Pathology, Weifang Medical University, Weifang, Shandong Province, China.

Cancer Science
|April 21, 2016
PubMed

Insights

MicroRNA-199a-5p (miR-199a-5p) inhibits breast cancer invasion by targeting Ets-1, reducing Ets-1 mRNA and protein levels. This mechanism downregulates β1 integrin, offering potential therapeutic strategies for breast cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNA-199a-5p (miR-199a-5p) is implicated in tumor invasion and metastasis in breast cancer.
  • The precise mechanism by which miR-199a-5p regulates Ets-1 in breast cancer remains unclear.

Purpose of the Study:

  • To elucidate the regulatory relationship between miR-199a-5p and Ets-1 in breast cancer.
  • To investigate the role of miR-199a-5p in modulating breast cancer cell invasion through Ets-1.
  • To identify the downstream targets and signaling pathways affected by miR-199a-5p-mediated Ets-1 regulation.

Main Methods:

  • Analysis of miR-199a-5p and Ets-1 expression in 158 primary breast cancer specimens.
  • In vitro experiments involving overexpression and knockdown of miR-199a-5p and Ets-1 in breast cancer cell lines (MCF-7, MDA-MB-231).
  • Luciferase reporter assays to confirm direct targeting of Ets-1 mRNA by miR-199a-5p.
  • Investigation of downstream signaling pathways including FAK/Src/Akt/mTOR and β1 integrin levels.

Main Results:

  • Ets-1 expression was inversely correlated with endogenous miR-199a-5p levels in breast cancer tissues.
  • Overexpression of miR-199a-5p significantly reduced Ets-1 mRNA and protein levels, while inhibition of miR-199a-5p increased Ets-1.
  • miR-199a-5p directly targets the 3'-UTR of Ets-1 mRNA, leading to decreased Ets-1 expression.
  • miR-199a-5p suppressed breast cancer cell motility and invasion, partly by downregulating β1 integrin via the FAK/Src/Akt/mTOR pathway.

Conclusions:

  • miR-199a-5p acts as a tumor suppressor in breast cancer by inhibiting cell invasion and metastasis.
  • The study establishes a direct regulatory link between miR-199a-5p and Ets-1, with miR-199a-5p silencing Ets-1 expression.
  • Targeting the miR-199a-5p-Ets-1-β1 integrin axis presents a potential therapeutic strategy for inhibiting breast cancer progression.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K